Market News & Trends
Evaxion to Develop Tailored Novel Cancer Vaccines Based Upon a New Untapped Source of AI-Discovered Targets
Evaxion Biotech A/S recently announced an expanded commitment to developing tailored cancer vaccines by targeting a novel category of AI-identified tumor antigens, named Endogenous Retroviruses…
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
Silo Pharma, Inc. recently announced its Alzheimer’s disease therapeutic SPC-14 showed positive efficacy in small animals. Data from a study conducted at Columbia University in collaboration…
Recipharm, Medspray & Resyca Enter Exclusive License Agreement to Develop Nasally Delivered Drug Products Using Proprietary Soft Mist Technology
Recipharm recently announced an exclusive license and collaboration agreement with Medspray and Resyca to develop soft mist nasal delivery devices for single and combination drug products. This collaboration….
Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
Ensysce Biosciences, Inc. recently announced receipt of notice from the US FDA that it has granted Breakthrough Therapy Designation (BTD) for PF614-MPAR. A next-generation opioid, PF614-MPAR represents a major….
Micropore Appoints Insung Chroma-Tech Co as Korean Distributor
UK-based particle engineering specialist Micropore Technologies has just announced the appointment of Insung Chroma-Tech Co. as the distributor for its patented membrane technology in the…
Colorcon Launches a New Titanium Dioxide-Free, High Opacity PVA-Based Coating for Pharmaceutical Tablets
Colorcon recently announced the launch of a new Opadry titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets. Annabel Bordmann, Film Coatings General Manager, said…
Biognosys Expands US Footprint With New Proteomics CRO Facility in Massachusetts
Biognosys recently announced the operational readiness of its new proteomics facility in Massachusetts. This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers…..
Vivtex Enters Research Collaboration With Astellas Pharma
Vivtex Corporation recently announced it has entered a research collaboration with Astellas Pharma Inc., a global pharmaceutical company. The collaboration is focused on the evaluation…
Artelo Biosciences Announces Publication of New Peer-Reviewed Preclinical Research Demonstrating Effectiveness in Treating & Preventing Oxaliplatin-Induced Peripheral Neuropathy
Artelo Biosciences, Inc. recently announced new research published in the peer-reviewed Journal of Pain. The research article, titled Discovery and preclinical evaluation of a novel inhibitor…
Alcami Announces Acquisition of West-Coast Based Pacific Pharmaceutical Services
Alcami Corporation recently announced it has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a preferred provider of….
Vaxxinity Announces Collaboration on Space Medicine Research With University of Central Florida
Vaxxinity, Inc. recently announced a collaboration with the University of Central Florida (UCF) to advance space medicine research. The research, funded by a grant from the…
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis & Treatment of Cancer & Other Diseases
Akoya Biosciences, Inc. recently announced the newly established Queensland Spatial Biology Centre (QSBC), located in Brisbane, Australia, is using the PhenoCycler-Fusion spatial biology platform as…
XOMA Expands its Commercial Royalty & Milestone Portfolio With DSUVIA Acquisition
XOMA Corporation recently announced it has acquired an economic interest in DSUVIA (sufentanil sublingual tablet) from Talphera, Inc., for $8 million. DSUVIA was approved in…
Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development & Manufacturing Organization
Kindeva Drug Delivery recently announced it has acquired Summit Biosciences Inc., an intranasal drug delivery contract development and manufacturing organization, from its founding….
Vivtex & AI Proteins Enter Strategic R&D Collaboration to Develop Novel, Oral Biologic Therapies for Inflammatory Diseases
Vivtex Corporation and AI Proteins, Inc. recently announced they have entered a strategic R&D collaboration to develop novel, oral biologic therapies for inflammatory diseases. The partners…
Credence MedSystems Announces a Significant Milestone Toward Scaling Manufacturing Capabilties
Credence MedSystems recently announced it has successfully completed Factory Acceptance Testing (FAT) for production of its Companion® injection device platform on the company’s new Clinical Assembly Line…..
Orphan Drug Designation Granted to PTX-252 by FDA for the Treatment of Acute Myeloid Leukaemia
Hyloris Pharmaceuticals SA recently announced the US FDA has granted Orphan Drug Designation to PTX-252 for the treatment of Acute Myeloid Leukaemia (AML). This product…
Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
Bora Pharmaceuticals Co., Ltd. recently announced its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer based in Minnesota, US, from shareholders, Sawai….
Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients With Glioblastoma Multiforme
Lisata Therapeutics, Inc. recently announced treatment of the first patient in a Phase 2a trial evaluating LSTA1 in patients with newly diagnosed glioblastoma multiforme (GBM).…
Vetter Becomes Member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Vetter has joined the German Association of Research-Based Pharmaceutical Companies (vfa) as an associate member. With this membership, the vfa recognizes the significant role that…
